D-0606-2022 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

FDA drug recall D-0606-2022 was initiated by Perrigo Company PLC on Oct 26, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier. The recall status is terminated (terminated Sep 29, 2023). Affected quantity: 21,4824 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 2, 2022
Initiation Date
Oct 26, 2021
Termination Date
Sep 29, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
21,4824 bottles

Product description

Severe Congestion No Drip Nasal Spray Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY DOLGENCORP, LLC, 100 MISSION RIDGE, GOODLETTSVILLE, TN 37072. NDC 55910-511-10

Reason for recall

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Distribution pattern

Nationwide in the USA

Code information

Batch: 1BK0716, Exp 12/31/2022); 1CK0899, Exp 01/31/2023; 1FK1163, Exp 01/31/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0606-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0606-2022. Report a data issue: hello@regdatalab.com.